IRIS Accounts Production v25.1.0.734 12809490 director 1.2.24 31.1.25 31.1.25 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh128094902024-01-31128094902025-01-31128094902024-02-012025-01-31128094902023-01-31128094902023-02-012024-01-31128094902024-01-3112809490ns15:EnglandWales2024-02-012025-01-3112809490ns14:PoundSterling2024-02-012025-01-3112809490ns10:Director12024-02-012025-01-3112809490ns10:PrivateLimitedCompanyLtd2024-02-012025-01-3112809490ns10:SmallEntities2024-02-012025-01-3112809490ns10:AuditExempt-NoAccountantsReport2024-02-012025-01-3112809490ns10:SmallCompaniesRegimeForDirectorsReport2024-02-012025-01-3112809490ns10:SmallCompaniesRegimeForAccounts2024-02-012025-01-3112809490ns10:FullAccounts2024-02-012025-01-3112809490ns10:OrdinaryShareClass12024-02-012025-01-3112809490ns10:RegisteredOffice2024-02-012025-01-3112809490ns5:CurrentFinancialInstruments2025-01-3112809490ns5:CurrentFinancialInstruments2024-01-3112809490ns5:ShareCapital2025-01-3112809490ns5:ShareCapital2024-01-3112809490ns5:RetainedEarningsAccumulatedLosses2025-01-3112809490ns5:RetainedEarningsAccumulatedLosses2024-01-3112809490ns5:ComputerEquipment2024-02-012025-01-3112809490ns5:ComputerEquipment2024-01-3112809490ns5:ComputerEquipment2025-01-3112809490ns5:ComputerEquipment2024-01-3112809490ns5:WithinOneYearns5:CurrentFinancialInstruments2025-01-3112809490ns5:WithinOneYearns5:CurrentFinancialInstruments2024-01-3112809490ns10:OrdinaryShareClass12025-01-3112809490ns5:RetainedEarningsAccumulatedLosses2024-01-3112809490ns5:RetainedEarningsAccumulatedLosses2024-02-012025-01-31
REGISTERED NUMBER: 12809490 (England and Wales)







FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JANUARY 2025

FOR

MB HEALTH CONSULTING LTD T/A THE HORMONE
CLINIC

MB HEALTH CONSULTING LTD T/A THE HORMONE
CLINIC (REGISTERED NUMBER: 12809490)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


MB HEALTH CONSULTING LTD T/A THE HORMONE
CLINIC

COMPANY INFORMATION
FOR THE YEAR ENDED 31 JANUARY 2025







DIRECTOR: Ms M Burke





REGISTERED OFFICE: 85 Great Portland Street
Great Portland Street
London
W1W 7LT





REGISTERED NUMBER: 12809490 (England and Wales)





ACCOUNTANTS: BENEDICTS
873 High Road
North Finchley
London
N12 8QA

MB HEALTH CONSULTING LTD T/A THE HORMONE
CLINIC (REGISTERED NUMBER: 12809490)

BALANCE SHEET
31 JANUARY 2025

2025 2024
Notes £    £    £   
FIXED ASSETS
Tangible assets 4 6,876 7,317

CURRENT ASSETS
Debtors 5 21,354 17,509
Cash at bank 519,765 288,266
541,119 305,775
CREDITORS
Amounts falling due within one year 6 109,500 86,850
NET CURRENT ASSETS 431,619 218,925
TOTAL ASSETS LESS CURRENT
LIABILITIES

438,495

226,242

PROVISIONS FOR LIABILITIES 1,719 -
NET ASSETS 436,776 226,242

CAPITAL AND RESERVES
Called up share capital 7 1 1
Retained earnings 8 436,775 226,241
SHAREHOLDERS' FUNDS 436,776 226,242

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

MB HEALTH CONSULTING LTD T/A THE HORMONE
CLINIC (REGISTERED NUMBER: 12809490)

BALANCE SHEET - continued
31 JANUARY 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 28 April 2025 and were signed by:





Ms M Burke - Director


MB HEALTH CONSULTING LTD T/A THE HORMONE
CLINIC (REGISTERED NUMBER: 12809490)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2025

1. STATUTORY INFORMATION

MB Health Consulting Ltd T/A The Hormone Clinic is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 33% on cost

Financial instruments
Basic financial instruments are recognised at amortised cost, except for investments in non-convertible preference and non-puttable ordinary shares which are measured at fair value, with changes recognised in profit or loss. Derivative financial instruments are initially recorded at cost and thereafter at fair value with changes recognised in profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


MB HEALTH CONSULTING LTD T/A THE HORMONE
CLINIC (REGISTERED NUMBER: 12809490)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2025

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 13 (2024 - 13 ) .

4. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 February 2024 15,096
Additions 5,724
At 31 January 2025 20,820
DEPRECIATION
At 1 February 2024 7,779
Charge for year 6,165
At 31 January 2025 13,944
NET BOOK VALUE
At 31 January 2025 6,876
At 31 January 2024 7,317

MB HEALTH CONSULTING LTD T/A THE HORMONE
CLINIC (REGISTERED NUMBER: 12809490)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2025

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 900 1,980
Rent -Deposit 10,000 10,000
Prepayments 10,454 5,529
21,354 17,509

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Taxation 81,724 62,946
Other creditors 1,687 -
Net wages 469 -
Directors' current accounts 6,240 20,171
Accruals 19,380 3,733
109,500 86,850

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £    £   
1 Ordinary 1 1 1

8. RESERVES
Retained
earnings
£   

At 1 February 2024 226,241
Profit for the year 242,534
Dividends (32,000 )
At 31 January 2025 436,775

9. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

During the year the company paid dividends of £32,000 (2024: £57,000) to the director.